Drawbacks of Dialysis Procedures for Removal of EDTA by Mónico, Andreia et al.
RESEARCH ARTICLE
Drawbacks of Dialysis Procedures for
Removal of EDTA
Andreia Mo´nico1, Eva Martı´nez-Senra1, F. Javier Cañada1, Silvia Zorrilla2, Dolores Pe´rez-
Sala1*
1 Department of Chemical and Physical Biology, Centro de Investigaciones Biolo´gicas, C.S.I.C., Madrid,
Spain, 2 Department of Cellular and Molecular Biology, Centro de Investigaciones Biolo´gicas, C.S.I.C.,
Madrid, Spain
* dperezsala@cib.csic.es
Abstract
Ethylenediaminetetraacetic acid (EDTA) is a chelating agent commonly used in protein puri-
fication, both to eliminate contaminating divalent cations and to inhibit protease activity. For
a number of subsequent applications EDTA needs to be exhaustively removed. Most purifi-
cation methods rely in extensive dialysis and/or gel filtration in order to exchange or remove
protein buffer components, including metal chelators. We report here that dialysis protocols,
even as extensive as those typically employed for protein refolding, may not effectively
remove EDTA, which is reduced only by approximately two-fold and it also persists after
spin-column gel filtration, as determined by NMR and by colorimetric methods. Remarkably,
the most efficient removal was achieved by ultrafiltration, after which EDTA became virtually
undetectable. These results highlight a potentially widespread source of experimental vari-
ability affecting free divalent cation concentrations in protein applications.
Introduction
Metal chelators, such as EDTA, are widely used for inhibition of proteases during protein puri-
fication or during preparation of cell or tissue extracts [1]. EDTA is also employed in proce-
dures to eliminate endotoxin from certain protein preparations [2] or to prevent oxidation by
metals [3]. However, the presence of EDTA in biological samples, even at low concentrations,
may interfere with assays like those aimed at assessing the effects of divalent cations on protein
or cellular functions and hence, it is often necessary to remove the chelator. Dialysis or gel fil-
tration are routinely used in research articles [2, 4] and recommended in commercial technical
application notes for exchange or removal of low molecular weight buffer components, includ-
ing EDTA, from cell or tissue extracts or protein preparations. Dialysis is also preferred when
the volume of protein available or its concentration are too low for size exclusion chromatog-
raphy with columns long enough to render a good separation. Moreover, dialysis is usually the
method of choice when the protein is purified from bacterial inclusion bodies and the dena-
tured protein needs to be refolded prior to the experiments by this procedure [5, 6]. This is the
case of intermediate filament proteins, which are typically purified using buffers containing
EDTA. In addition, they require solubilization either from inclusion bodies, in the case of
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recombinant proteins expressed in bacteria, or from insoluble eukaryotic cell cytoskeletal frac-
tions, for which high urea concentrations, up to 9.5 M, are used [7–9]. Later, the denatured
proteins are refolded by step-wise dialysis to gradually remove urea, usually in low salt buffer
to keep the protein unassembled, as high ionic strength triggers polymerization [8]. In fact,
intermediate filament proteins such as desmin, vimentin or glial fibrillary acidic protein
(GFAP) purified through these methods, have been widely studied to assess polymerization or
association changes induced by increasing ionic strength or by divalent cations, usually at mil-
limolar concentrations [9, 10].
Nevertheless, confirmation of adequate elimination of additives used during purification or
refolding is necessary for subsequent applications, above all, when studying the impact of low
concentrations of various ligands on protein structure or function. Here we show that EDTA
can be carried on unnoticed during protein dialysis. Moreover, we provide simple methods for
its detection and improved removal.
Materials and Methods
Materials
Amicon ultrafiltration devices (10K cut off) were from Millipore. PD-SpinTrap G-25 columns
were from GE Healthcare. Slide-A-Lyzer MINI Dialysis devices (20K cut off) were from
Thermo. 96-well plates were from Falcon. Recombinant hamster vimentin was from Cytoskel-
eton, Inc. Recombinant human vimentin was from Biomedal (Sevilla, Spain). Other reagents
were of the highest quality from Sigma.
Protein dialysis
Bovine serum albumin (BSA) at 1 mg/ml in 5 mM Pipes, pH 7.0 containing 1 mM EDTA was
dialyzed against 5 mM Pipes, 1 mM DTT, pH 7.0 with four buffer changes and, subsequently,
into 5 mM Pipes, 0.25 mM DTT, pH 7.0 with two changes. Dialysis of vimentin followed the
standard refolding protocol [8]. Briefly, the human recombinant protein at 1 mg/ml in 5 mM
Tris-HCl, pH 7.6, containing 8 M urea, 1 mM EDTA, 10 mM β-mercaptoethanol, 0.4 mM
PMSF and approximately 150 mM KCl, was subjected to step-wise dialysis against 5 mM Pipes
pH 7.0, 1 mM DTT containing 6 M urea, then 4 M urea, 2 M urea and no urea at r.t., and
finally, to two additional steps against 5 mM Pipes, pH 7.0, 0.25 mM DTT, the last one for 16 h
at 16˚C.
Spin-column gel filtration and ultrafiltration
Gel filtration was conducted using PD SpinTrap G-25 1 ml columns equilibrated with 5 mM
Pipes, 0.1 mM DTT, pH 7.0, before loading 140 μl samples of vimentin or BSA and eluting
according to the instructions of the manufacturer. For ultrafiltration, BSA or vimentin samples
(250 μl) containing 1 mM EDTA were diluted 10-fold with EDTA-free buffer, applied to Milli-
pore Amicon Ultra filter units (10 K pore size) and centrifuged at 3000xg for 15 min at 16˚C,
which concentrated the samples down to their original volume. Then, samples were diluted
again 10-fold with buffer without EDTA and the procedure was repeated.
Colorimetric estimation of EDTA concentration
The concentration of EDTA in the protein solutions was estimated through a colorimetric
assay by monitoring its competition with 4-(2-pyridylazo)-resorcinol (PAR) for Zn binding.
The binding of zinc to PAR forms a colored complex with absorbance at 492 nm [11]. The
presence of EDTA induces a decrease in the formation of this complex. A calibration curve
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was obtained by titration of samples containing 100 μM PAR and 10 μM Zn with known con-
centrations of EDTA and measuring the absorbance at 492 nm, using a Varioskan Flash
(Thermo) microplate reader. The amount of EDTA in the protein preparations was deter-
mined from their absorbance at 492 nm after incubation with 100 μM PAR and 10 μM Zn,
and extrapolation using the calibration curve. Sample volumes of 1 to 10 μl were used in a typi-
cal total assay volume of 100 μl. Measurements were performed 5 min after mixing of reagents.
NMR analysis
NMR spectra were acquired in a 500 MHz Bruker AVANCE equipped with a SEF 19F-1H
probe or a 600MHz Bruker AVANCE equipped with a cryogenic triple resonance TXI probe.
In the case of samples dissolved in deuterated buffer (20 mM deuterated Tris, Cambridge Iso-
tope, UK), spectra were acquired with a simple 90˚ pulse sequence (zg Bruker pulse sequence)
and with 32K data points and 2 second recovery delay and 10 ppm of spectral width centered
at 4.7 ppm (chemical shift of residual HDO signal). In the case of samples dissolved in non-
deuterated buffers, a 10% volume of deuterated water was added for locking deuterium signal
and the standard Bruker pulse sequence “zgesgp” using excitation sculpting gradients for
water signal suppression was used. The spectra were acquired at 25˚C with 32K points, 2 sec-
ond recovery delay and 14 ppm of spectral width centered at 4.7 ppm (chemical shift of water).
The spectra were acquired using from 8 to 2048 scans depending on the sample concentration;
no line broadening was applied in the processing. Bruker TOPSPIN software was used for
acquisition and processing the spectra. For testing the pH dependency of chemical shift signals
of EDTA, samples of 1 to 3 mM EDTA, with and without cation (Ca2+, Zn2+, Mg2+ or La3+), in
20 mM deuterated Tris were prepared at different pH (between 5 and 9) by acidification with
deuterated hydrochloric acid. The actual pH was measured after the addition of the corre-
sponding dichloride salt of each cation. EDTA and ZnCl2 solutions were prepared in deuter-
ated water.
Results and Discussion
We have recently explored protein modification by electrophilic lipids using both cultured
cells and commercially available protein preparations, including the IF protein vimentin [12,
13]. In order to study the effect of micromolar concentrations of divalent cations on these pro-
cesses we set out to rule out the presence of metal chelators in the protein preparation. For this
we first conducted NMR experiments. Proton NMR has been previously used for detecting
either EDTA or divalent cations as their EDTA chelates in blood samples obtained with EDTA
as anticoagulant [14, 15]. In addition, NMR methods have been employed to quantitate metals
in human serum upon addition of exogenous EDTA [16]. As shown in Fig 1, free EDTA gives
two singlet peaks, the one at low field corresponding to the 8 methylene protons of acetyl moi-
eties, and the one at high field to the 4 protons of the ethylenediamine moiety. The shifts of
these peaks are strongly dependent on the pH of the sample and their signals show a significant
broadening at low pH (Fig 1). Moreover, complexation of EDTA with different metals gives
rise to characteristic patterns, where the methylene protons of acetyl moieties become un-
equivalent, resulting in differentiated signals due to the characteristic structures of the chelates,
as depicted in Fig 1 for the EDTA-calcium complex. This ensures the specificity of the detec-
tion and minimizes pH dependence, since the shifts of the signals of the complexed EDTA
form appear constant in this pH range (Fig 1 and [16]).
Therefore, protein samples were analyzed after adding known amounts of a divalent cation
such as calcium or zinc, the latter case being illustrated in Fig 2. This revealed the presence of a
substantial amount of EDTA in a commercial sample, which is presented as a lyophilized
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preparation that after reconstitution in water should yield a solution of folded protein in 5
mM Pipes pH 7.0, 1 mM DTT, 5% (w/v) sucrose and 1% (w/v) dextran. In order to obtain a
preparation more suitable for our studies we subjected a human vimentin sample in buffer
containing 8 M urea, 5 mM Tris-HCl pH 7.6, 1 mM EDTA, 10 mM β-mercaptoethanol, 0.4
mM PMSF and approximately 150 mM KCl to the typical renaturation dialysis procedure,
which included four sequential steps with at least six changes against EDTA-free buffers [8].
NMR analysis of the protein solutions thus obtained showed the retention of EDTA after dialy-
sis (Fig 2A).
A complementary colorimetric assay was also used to further confirm the presence of
EDTA and to estimate its levels in the protein preparations after dialysis. For this we took
advantage of the ability of the compound 4-(2-pyridylazo)-resorcinol (PAR) to form a colored
2:1 complex with zinc with high affinity (effective dissociation constant of the Zn(PAR)2 com-
plex, at pH 7.0, 2.1 x 10−12 M2 [17]), which presents an absorption maximum at 492 nm and
can be measured spectrophotometrically. In turn, EDTA forms a 1:1 complex with zinc of
extremely high affinity: 6 x 10−14 M at pH 7.0 [18]. Therefore, solutions containing EDTA
should compete with PAR for zinc binding, in such a way that the decrease in the absorption
at 492 nm measured at the equilibrium can be used to infer the concentration of EDTA present
in the sample. For this, we titrated known amounts of EDTA into 100 μM PAR and 10 μM
zinc assay mixtures and measured the absorbance at 492 nm to build a calibration curve (Fig
2B, upper panel). We then assayed the EDTA present in the dialysates from their absorbance
Fig 1. Proton NMR spectra of EDTA and its Ca2+-complexed forms at different pH. EDTA (3 mM) and
CaCl2 (1.5 mM) were mixed in deuterated Tris buffer to yield equimolecular amounts of free and Ca2+-
complexed EDTA. Proton NMR spectra of the mixture were acquired at different pH: (A) pH 8.2, (B) pH 7.0,
(C) pH 5.9. The signals corresponding to protons of the free and Ca2+-complexed forms of EDTA are
indicated. The NMR spectrum of EDTA alone is identical to that of free EDTA presented. The moieties
responsible for each of the components of the signals are depicted in bold. The signal corresponding to Tris
buffer is labeled with *.
doi:10.1371/journal.pone.0169843.g001
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when mixed with the above specified concentrations of PAR and zinc. These measurements
evidenced that samples of vimentin or bovine serum albumin (BSA) originally containing 1
mM EDTA still retained ~450 μM EDTA after dialysis, in good agreement with parallel deter-
minations by NMR (Fig 2A). Therefore, EDTA removal can be easily and conveniently moni-
tored by this procedure. Nevertheless, it should be taken into account that other metal-binding
compounds or proteins present in the sample may also compete with PAR for zinc binding,
for which detection of EDTA by several methods is advisable. EDTA was also not removed
from solutions of other intermediate filament proteins such as GFAP or desmin treated under
similar conditions (unpublished observations).
As the amount of EDTA remaining in the samples was incompatible with many protein
studies, we attempted to setup a procedure to effectively remove this chelator. Bearing in mind
that the quantity of protein available for biological assays is often limited, we used protocols
for small sample volumes, namely, spin column gel filtration and ultrafiltration (Fig 3A). We
started by processing the protein solutions already subjected to dialysis by spin-column gel fil-
tration. Although EDTA was further reduced by this treatment, the protein solutions still con-
tained ~200 μM EDTA, as determined by the PAR competition assay (Fig 3B). As an
alternative, we turned to ultrafiltration to remove the EDTA. BSA or vimentin samples con-
taining 1 mM EDTA were diluted 10-fold with EDTA-free buffer and ultrafiltrated as indi-
cated in Fig 3A, which concentrated the samples down to their original volume. Then, samples
were diluted again 10-fold with buffer without EDTA and the procedure was repeated. Finally,
assessment of EDTA content by the colorimetric assay confirmed that EDTA was more
Fig 2. Detection and quantitation of EDTA in protein samples. (A) NMR analysis. Upper panel: 500MHz
1D-proton NMR spectrum of a commercial sample of vimentin (0.7 μM) with added 150 μM ZnCl2. Signals for
the protons of sucrose, a stabilizer present in the sample as indicated in specifications, and those of PIPES
buffer are easily identified. An additional singlet at 2.79 ppm and two coupled doublets at 3.25 and 3.32 ppm
(2JHH = 17.3 Hz) are also observed. Middle panel: reference proton spectrum of EDTA in presence of Zn2+,
the two coupled doublets corresponding to the AB spin system of the methylene protons of the four acetyl
groups, non-equivalent due to the structure of the metal chelate, and the singlet corresponding to the four
equivalent protons of the ethylenediamine moiety are apparent. Lower panel: reference proton spectrum of
EDTA at pH 7.2, only the two characteristic singlets of uncomplexed EDTA appear. (B) Detection of EDTA
by colorimetric analysis. Upper panel: Calibration curve showing the dependence on EDTA concentration of
the absorbance at 492 nm of mixtures containing 100 μM PAR and 10 μM ZnCl2. Lower panel: Amount of
EDTA remaining in samples from vimentin and BSA subjected to extensive dialysis as determined from the
absorbance at 492 nm after incubation with PAR and ZnCl2, using the calibration curve. Initial EDTA
concentration in the samples was 1 mM. Data shown are mean ± SD of 4 assays.
doi:10.1371/journal.pone.0169843.g002
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effectively removed by this procedure (Fig 3B). At this point, EDTA was not detectable by
NMR, limiting its possible concentration to 10 μM or lower in the undiluted protein sample
(Fig 3C). A further advantage of this method is that protein dilution can be minimized by
monitoring the final retentate volume. Lastly, combination of ultrafiltration and dialysis led to
the reduction of EDTA in the protein samples below 5 μM according to the colorimetric assay
(Fig 3B).
We have found numerous examples in the literature and in technical notes and protocols
where dialysis is employed to remove EDTA. In contrast, evidences on the limitations of this
method to completely remove the chelator are scarce and not readily found in bibliographic
searches. Our observations together with these previous works [19, 20] indicate that it should
not be assumed that EDTA is thoroughly removed by dialysis procedures. Thus, complete
removal of EDTA should be assessed either by the procedures described herein or by other
available methods, like HPLC or spectrometric procedures [21, 22], as in [19]. The efficiency
of EDTA removal by dialysis may vary with buffer composition. In particular, Kuzmenko
et al., showed that EDTA removal was poorer when dialysing against buffers with low ionic
strength [19], with incomplete removal even after six buffer changes over three days dialysis.
To test the influence of ionic strength on the effectiveness of dialysis under our experimental
conditions, we have assessed the removal of EDTA (1 mM initial concentration) from a BSA
Fig 3. Procedures for EDTA removal from protein samples and detection of EDTA. (A) The protein
samples containing 1 mM EDTA were subjected to the indicated purification procedures. Left panel: Samples
of BSA or vimentin were subjected to spin column gel filtration as detailed in methods. Right panel: protein
samples were applied to Millipore Amicon Ultra filter units (10 K pore size) and subjected to two rounds of
ultrafiltration, as described in the text. (B) Colorimetric determination of EDTA present in protein samples after
diverse purification procedures using the PAR competition assay. Results shown are mean ± SD of 4 (dialysis
plus gel filtration), 2 to 7 (ultrafiltration), or 3 to 7 (ultrafiltration plus dialysis) assays. (C) NMR analysis. Upper
panel: 600MHz 1D-proton NMR spectrum of an ultrafiltrated sample of vimentin (1.8 μM final concentration).
Signals of buffer and additives used in the purification (glycerol, from the ultrafiltration filters, and DTT) are
observed. Protein signals appear at baseline noise level and are not recognizable. Middle panel: The same
sample analyzed in the upper panel monitored after addition of 150 μM of ZnCl2. A quadruplet that appears at
3.92 ppm corresponds to trifluoroethanol added for referencing. Lower panel: monitorization of the sample
after addition of 20 μM EDTA. The signal pattern of the AB system at 3.32 and 3.25 ppm and the singlet at
2.79 ppm corresponding to the Zn2+-EDTA chelate are clearly visible.
doi:10.1371/journal.pone.0169843.g003
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sample by dialysis performed as in Fig 2, except that 150 mM NaCl was included in all the dial-
ysis buffers and the procedure was carried out at r.t. Under these conditions, EDTA remaining
in the protein sample was only 33.5 ± 35.0 μM (average value ± SD of 7 determinations), com-
pared to 290.5 ± 23.4 μM EDTA remaining in the absence of NaCl (mean ± SD of 5 determina-
tions). Therefore, these results confirm the previous observations [19] and show the superior
effectiveness of EDTA removal by dialysis at physiological ionic strength.
The concentration of EDTA remaining after dialysis will likely not affect the results of stud-
ies employing millimolar concentrations of divalent cations [23], which in some cases are even
performed in the presence of 1 mM EDTA [9]. Nevertheless, they should be taken into account
when performing assays with micromolar concentrations of metals. The presence of EDTA
can also affect various protein parameters, like thermal denaturation [20], or induce pH alter-
ations upon addition of divalent cations [24]. Also, in studies assessing the biological effects of
dialyzed proteins or cellular or plasma fractions, residual EDTA could be responsible for some
of the effects observed.
Potential reasons for the lack of effectiveness of dialysis procedures could include the
reported ability of EDTA to form supramolecular aggregates in solution, as well as its capacity
to associate with proteins ([25] and references therein). For instance, EDTA has been reported
to bind to α-lactalbumin altering the equilibrium between different conformers of the protein
and its apparent thermal stability [26].
Size exclusion chromatography using spin desalting columns was among the methods we
evaluated to diminish the concentration of EDTA and we found this procedure less effective
compared with ultrafiltration. However, we cannot rule out that the use of longer columns
with higher resolution may improve the species separation. In addition, care should be exer-
cised with other chromatographic procedures employed in protein purification since EDTA
has been reported to be abnormally retained in ion exchange chromatography under certain
conditions [24].
Conclusions
Results presented here show that, despite its low molecular mass (292.24 Da), EDTA is often
retained inside dialysis bags with pore-sizes over a hundred times larger, and extending the
dialysis time and the number of buffer changes does not seem to allow successful removal of
the chelator in those cases. Therefore, determination of the level of EDTA in the dialysates is
needed whenever interference of this compound with the intended assays is suspected. For an
initial assessment of the potential presence of EDTA, we suggest a fast and cost-efficient
method, suitable for small sample amounts, which is based on the competition of EDTA and
the zinc-binding compound PAR for complexation of this divalent cation. After testing proce-
dures other than dialysis routinely employed to separate macromolecules from small com-
pounds, we concluded that ultracentrifugation could be a good choice to remove EDTA when
necessary. Moreover, when the protein needs to be subjected to dialysis as part of a refolding
protocol, the combination of dialysis and ultrafiltration in no particular order renders opti-
mum results in terms of chelator elimination.
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